Urokinase induces matrix metalloproteinase-9/gelatinase B expression in THP-1 monocytes via ERK1/2 and cytosolic phospholipase A2 activation and eicosanoid production

Journal of Vascular Research

Volumn 43, Issue 5, 2006, Pages 482-490

  Menshikov, Mikhail ^a   Torosyan, Narine ^a   Elizarova, Eugenia ^a   Plakida, Karina ^a   Vorotnikov, Alexander ^a   Parfyonova, Yelena ^a   Stepanova, Victoria ^a   Bobik, Alex ^b   Berk, Bradford ^c   Tkachuk, Vsevolod ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Eicosanoids; Matrix metalloproteinase; Migration; Phospholipase A2; Urokinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOVIRUS VECTOR; BISINDOLYLMALEIMIDE; GELATINASE B; GENISTEIN; HERBIMYCIN A; ICOSANOID; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHONIC ACID DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C INHIBITOR; UROKINASE;

ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; MONOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION;

CELL LINE; CELL MOVEMENT; EICOSANOIDS; ENZYME ACTIVATION; HUMANS; KINETICS; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; URINARY PLASMINOGEN ACTIVATOR;

EID: 33748757658     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095248     Document Type: Article

References (25)

1. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005;85:1-31.
2. Kennedy SH, Qin H, Lin L, Tan EML: Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. Am J Pathol 1995;146:764-771.
3. Kleinman HK, McGarvey ML, Hassel JR, Star VL, Cannon FB, Laurie GW, Martin GR: Basement membrane complexes with biological activity. Biochemistry 1986;25:312-318.
4. Zhang Y, McCluskey K, Fujii K, Wahl LM: Differential regulation of monocyte matrix metalloproteinase and TIMP-I production by TNF-α, granulocyte-macrophage CSF, and IL-1β through prostaglandin-dependent and -independent mechanisms. J Immunol 1998;161:3071-3076.
5. Cho A, Graves J, Reidy M: Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000;20:2527-2532.
6. Shankavarah UT, DeWitt DL, Wahl LM: Lipopolysaccharide induction of monocyte matrix metalloproteinases is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2. J Leukoc Biol 1998;64:221-227.
7. 2 receptor. J Biol Chem 1996;271:27744-27750.
8. Kanse SM, Benzakour O, Kanthou C, Kost C, Lijnen HR, Preissner KT: Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arterioscler Thromb Vasc Biol 1997;17:2848-2854.
9. Behrendt N, Ronne E, Dano K: The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol Chem Hoppe Seyler 1995;376:269-279.
10. Busso N, Masur SK, Lazega D, Waxman S, Ossowski L: Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 1994;126:259-270.
11. Tang H, Kerins DM, Hao Q, Inagami T, Vaughan DE: The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem 1998;273:18268-18272.
12. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP: Activation of matrix metalloproteinase-9 (MMP-9) via converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-13076.
13. Inuzuka K, Ogata Y, Nagase H, Shirouzu K: Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma. J Surg Res 2000;93:211-218.
14. Menshikov MYu, Elizarova EP, Kudryashova E, Timofeeva AV, Khaspekov GL, Beabealashvilli Rsh, Bobik A: Plasmin-independent gelatinase B (matrix metalloproteinase-9) release by monocytes under the influence of urokinase. Biochemistry (Moscow) 2001;66:954-959.
15. Menshikov M, Elizarova E, Plakida K, Timofeeva A, Khaspekov G, Beabealashvilli R, Bobik A, Tkachuk V: Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis. Biochem J 2002;367:833-839.
16. Stepanova V, Bobik A, Bibilashvili R, Belogurov A, Rybalkin I, Domogatsky S, Little PJ, Goncharova E, Tkachuk V: Urokinase plasminogen activator induces smooth muscle cell migration: key role of growth factor-like domain. FEBS Lett 1997;414:471-474.
17. Poliakov AA, Mukhina SA, Traktouev DO, Bibilashvily RSh, Gursky YG, Minashkin MM, Stepanova VV, Tkachuk VA: Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains. J Recept Signal Transduct Res 1999;19:939-951.
18. Mukhina S, Stepanova V, Traktouev D, Poliakov A, Beabealashvilly R, Gursky Y, Minashkin M, Shevelev A, Tkachuk V: The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis. J Biol Chem 2000;275:16450-16458.
19. Gyetko MR, Todd RF 3rd, Wilkinson CC, Sitrin RG: The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 1994;93:1380-1387.
20. Rabbani SA, Mazar AP, Bernier SM, Haq M, Bolivar I, Henkin J, Goltzman D: Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem 1992;267:14151-14156.
21. Konakova M, Hucho F, Schleuning WD: Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur J Biochem 1998;253:421-429.
22. Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L: Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 2001;12:863-879.
23. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D: Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase-1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 1996;271:10672-10680.
24. Nemenoff RA, Winitz S, Qian NX, Van Putten V, Johnson GL, Heasley LE: Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem 1993;268:1960-1964.
25. Xing M, Tao L, Insel PA: Role of extracellular signal-regulated kinase and PKC alpha in cytosolic PLA2 activation by bradykinin in MDCK-D1 cells. Am J Physiol 1997;272:C1380-C1387.